Recent developments in cancer care continue to offer optimism for patients. Scientists are diligently exploring cutting-edge approaches, including immune therapies , targeted therapies , and individualized approaches. A significant study published this week demonstrates the potential of a experimental drug in treating metastatic NSCLC. Furthermore,